drugset / Trial / NCT04941833

Desogestrel for the Preoperative Treatment of Endometrioma Compared With Placebo

NCT04941833

RandomizedSingle-groupDouble-blindTreatment

Summary

Use of the oral desogestrel compared with placebo for preoperative treatment of endometrioma in the patient who underwent to surgery in next 3 months The result will be evaluated on cyst diameter, the associated pain and side effect of the oral desogestrel.

Timeline

Start
2021-06-01
Primary completion
2022-07-31
Completion
2022-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Desogestrel Small molecule 0.075 mg Oral

Indications